Medical Care
Nucleic Acid Amplification Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 18, 24
- ID: 551713
- Pages: 98
- Figures: 159
- Views: 1
The global market for Nucleic Acid Amplification Testing was estimated to be worth US$ 133.5 million in 2023 and is forecast to a readjusted size of US$ 184.9 million by 2030 with a CAGR of 4.3% during the forecast period 2024-2030
North American market for Nucleic Acid Amplification Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Nucleic Acid Amplification Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Nucleic Acid Amplification Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Nucleic Acid Amplification Testing include Roche, Becton Dickinson, Beckman Coulter, Abbott, Illumina, Siemens Healthineers, bioMerieux, Novartis and Bio-Rad Laboratories, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nucleic Acid Amplification Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Nucleic Acid Amplification Testing by region & country, by Type, and by Application.
The Nucleic Acid Amplification Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acid Amplification Testing.
Market Segmentation
By Company
Roche
Becton Dickinson
Beckman Coulter
Abbott
Illumina
Siemens Healthineers
bioMerieux
Novartis
Bio-Rad Laboratories
Segment by Type:
Target Amplification Systems
Probe Amplification Systems
Signal Amplification
Segment by Application
Infectious Diseases
Cancer
Personalized Medicine
Genetic and Mitochondrial Disorders
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Nucleic Acid Amplification Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Nucleic Acid Amplification Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Nucleic Acid Amplification Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
North American market for Nucleic Acid Amplification Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Nucleic Acid Amplification Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Nucleic Acid Amplification Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Nucleic Acid Amplification Testing include Roche, Becton Dickinson, Beckman Coulter, Abbott, Illumina, Siemens Healthineers, bioMerieux, Novartis and Bio-Rad Laboratories, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nucleic Acid Amplification Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Nucleic Acid Amplification Testing by region & country, by Type, and by Application.
The Nucleic Acid Amplification Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acid Amplification Testing.
Market Segmentation
By Company
Roche
Becton Dickinson
Beckman Coulter
Abbott
Illumina
Siemens Healthineers
bioMerieux
Novartis
Bio-Rad Laboratories
Segment by Type:
Target Amplification Systems
Probe Amplification Systems
Signal Amplification
Segment by Application
Infectious Diseases
Cancer
Personalized Medicine
Genetic and Mitochondrial Disorders
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Nucleic Acid Amplification Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Nucleic Acid Amplification Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Nucleic Acid Amplification Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Nucleic Acid Amplification Testing Product Introduction
1.2 Global Nucleic Acid Amplification Testing Market Size Forecast
1.3 Nucleic Acid Amplification Testing Market Trends & Drivers
1.3.1 Nucleic Acid Amplification Testing Industry Trends
1.3.2 Nucleic Acid Amplification Testing Market Drivers & Opportunity
1.3.3 Nucleic Acid Amplification Testing Market Challenges
1.3.4 Nucleic Acid Amplification Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Nucleic Acid Amplification Testing Players Revenue Ranking (2023)
2.2 Global Nucleic Acid Amplification Testing Revenue by Company (2019-2024)
2.3 Key Companies Nucleic Acid Amplification Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Nucleic Acid Amplification Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of Nucleic Acid Amplification Testing
2.6 Nucleic Acid Amplification Testing Market Competitive Analysis
2.6.1 Nucleic Acid Amplification Testing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Nucleic Acid Amplification Testing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Amplification Testing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Target Amplification Systems
3.1.2 Probe Amplification Systems
3.1.3 Signal Amplification
3.2 Global Nucleic Acid Amplification Testing Sales Value by Type
3.2.1 Global Nucleic Acid Amplification Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Nucleic Acid Amplification Testing Sales Value, by Type (2019-2030)
3.2.3 Global Nucleic Acid Amplification Testing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Infectious Diseases
4.1.2 Cancer
4.1.3 Personalized Medicine
4.1.4 Genetic and Mitochondrial Disorders
4.2 Global Nucleic Acid Amplification Testing Sales Value by Application
4.2.1 Global Nucleic Acid Amplification Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Nucleic Acid Amplification Testing Sales Value, by Application (2019-2030)
4.2.3 Global Nucleic Acid Amplification Testing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Nucleic Acid Amplification Testing Sales Value by Region
5.1.1 Global Nucleic Acid Amplification Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Nucleic Acid Amplification Testing Sales Value by Region (2019-2024)
5.1.3 Global Nucleic Acid Amplification Testing Sales Value by Region (2025-2030)
5.1.4 Global Nucleic Acid Amplification Testing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Nucleic Acid Amplification Testing Sales Value, 2019-2030
5.2.2 North America Nucleic Acid Amplification Testing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Nucleic Acid Amplification Testing Sales Value, 2019-2030
5.3.2 Europe Nucleic Acid Amplification Testing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Nucleic Acid Amplification Testing Sales Value, 2019-2030
5.4.2 Asia Pacific Nucleic Acid Amplification Testing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Nucleic Acid Amplification Testing Sales Value, 2019-2030
5.5.2 South America Nucleic Acid Amplification Testing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Nucleic Acid Amplification Testing Sales Value, 2019-2030
5.6.2 Middle East & Africa Nucleic Acid Amplification Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Nucleic Acid Amplification Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Nucleic Acid Amplification Testing Sales Value
6.3 United States
6.3.1 United States Nucleic Acid Amplification Testing Sales Value, 2019-2030
6.3.2 United States Nucleic Acid Amplification Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Nucleic Acid Amplification Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Nucleic Acid Amplification Testing Sales Value, 2019-2030
6.4.2 Europe Nucleic Acid Amplification Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Nucleic Acid Amplification Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Nucleic Acid Amplification Testing Sales Value, 2019-2030
6.5.2 China Nucleic Acid Amplification Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Nucleic Acid Amplification Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Nucleic Acid Amplification Testing Sales Value, 2019-2030
6.6.2 Japan Nucleic Acid Amplification Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Nucleic Acid Amplification Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Nucleic Acid Amplification Testing Sales Value, 2019-2030
6.7.2 South Korea Nucleic Acid Amplification Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Nucleic Acid Amplification Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Nucleic Acid Amplification Testing Sales Value, 2019-2030
6.8.2 Southeast Asia Nucleic Acid Amplification Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Nucleic Acid Amplification Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Nucleic Acid Amplification Testing Sales Value, 2019-2030
6.9.2 India Nucleic Acid Amplification Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Nucleic Acid Amplification Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Roche
7.1.1 Roche Profile
7.1.2 Roche Main Business
7.1.3 Roche Nucleic Acid Amplification Testing Products, Services and Solutions
7.1.4 Roche Nucleic Acid Amplification Testing Revenue (US$ Million) & (2019-2024)
7.1.5 Roche Recent Developments
7.2 Becton Dickinson
7.2.1 Becton Dickinson Profile
7.2.2 Becton Dickinson Main Business
7.2.3 Becton Dickinson Nucleic Acid Amplification Testing Products, Services and Solutions
7.2.4 Becton Dickinson Nucleic Acid Amplification Testing Revenue (US$ Million) & (2019-2024)
7.2.5 Becton Dickinson Recent Developments
7.3 Beckman Coulter
7.3.1 Beckman Coulter Profile
7.3.2 Beckman Coulter Main Business
7.3.3 Beckman Coulter Nucleic Acid Amplification Testing Products, Services and Solutions
7.3.4 Beckman Coulter Nucleic Acid Amplification Testing Revenue (US$ Million) & (2019-2024)
7.3.5 Abbott Recent Developments
7.4 Abbott
7.4.1 Abbott Profile
7.4.2 Abbott Main Business
7.4.3 Abbott Nucleic Acid Amplification Testing Products, Services and Solutions
7.4.4 Abbott Nucleic Acid Amplification Testing Revenue (US$ Million) & (2019-2024)
7.4.5 Abbott Recent Developments
7.5 Illumina
7.5.1 Illumina Profile
7.5.2 Illumina Main Business
7.5.3 Illumina Nucleic Acid Amplification Testing Products, Services and Solutions
7.5.4 Illumina Nucleic Acid Amplification Testing Revenue (US$ Million) & (2019-2024)
7.5.5 Illumina Recent Developments
7.6 Siemens Healthineers
7.6.1 Siemens Healthineers Profile
7.6.2 Siemens Healthineers Main Business
7.6.3 Siemens Healthineers Nucleic Acid Amplification Testing Products, Services and Solutions
7.6.4 Siemens Healthineers Nucleic Acid Amplification Testing Revenue (US$ Million) & (2019-2024)
7.6.5 Siemens Healthineers Recent Developments
7.7 bioMerieux
7.7.1 bioMerieux Profile
7.7.2 bioMerieux Main Business
7.7.3 bioMerieux Nucleic Acid Amplification Testing Products, Services and Solutions
7.7.4 bioMerieux Nucleic Acid Amplification Testing Revenue (US$ Million) & (2019-2024)
7.7.5 bioMerieux Recent Developments
7.8 Novartis
7.8.1 Novartis Profile
7.8.2 Novartis Main Business
7.8.3 Novartis Nucleic Acid Amplification Testing Products, Services and Solutions
7.8.4 Novartis Nucleic Acid Amplification Testing Revenue (US$ Million) & (2019-2024)
7.8.5 Novartis Recent Developments
7.9 Bio-Rad Laboratories
7.9.1 Bio-Rad Laboratories Profile
7.9.2 Bio-Rad Laboratories Main Business
7.9.3 Bio-Rad Laboratories Nucleic Acid Amplification Testing Products, Services and Solutions
7.9.4 Bio-Rad Laboratories Nucleic Acid Amplification Testing Revenue (US$ Million) & (2019-2024)
7.9.5 Bio-Rad Laboratories Recent Developments
8 Industry Chain Analysis
8.1 Nucleic Acid Amplification Testing Industrial Chain
8.2 Nucleic Acid Amplification Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Nucleic Acid Amplification Testing Sales Model
8.5.2 Sales Channel
8.5.3 Nucleic Acid Amplification Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Nucleic Acid Amplification Testing Product Introduction
1.2 Global Nucleic Acid Amplification Testing Market Size Forecast
1.3 Nucleic Acid Amplification Testing Market Trends & Drivers
1.3.1 Nucleic Acid Amplification Testing Industry Trends
1.3.2 Nucleic Acid Amplification Testing Market Drivers & Opportunity
1.3.3 Nucleic Acid Amplification Testing Market Challenges
1.3.4 Nucleic Acid Amplification Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Nucleic Acid Amplification Testing Players Revenue Ranking (2023)
2.2 Global Nucleic Acid Amplification Testing Revenue by Company (2019-2024)
2.3 Key Companies Nucleic Acid Amplification Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Nucleic Acid Amplification Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of Nucleic Acid Amplification Testing
2.6 Nucleic Acid Amplification Testing Market Competitive Analysis
2.6.1 Nucleic Acid Amplification Testing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Nucleic Acid Amplification Testing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Amplification Testing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Target Amplification Systems
3.1.2 Probe Amplification Systems
3.1.3 Signal Amplification
3.2 Global Nucleic Acid Amplification Testing Sales Value by Type
3.2.1 Global Nucleic Acid Amplification Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Nucleic Acid Amplification Testing Sales Value, by Type (2019-2030)
3.2.3 Global Nucleic Acid Amplification Testing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Infectious Diseases
4.1.2 Cancer
4.1.3 Personalized Medicine
4.1.4 Genetic and Mitochondrial Disorders
4.2 Global Nucleic Acid Amplification Testing Sales Value by Application
4.2.1 Global Nucleic Acid Amplification Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Nucleic Acid Amplification Testing Sales Value, by Application (2019-2030)
4.2.3 Global Nucleic Acid Amplification Testing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Nucleic Acid Amplification Testing Sales Value by Region
5.1.1 Global Nucleic Acid Amplification Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Nucleic Acid Amplification Testing Sales Value by Region (2019-2024)
5.1.3 Global Nucleic Acid Amplification Testing Sales Value by Region (2025-2030)
5.1.4 Global Nucleic Acid Amplification Testing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Nucleic Acid Amplification Testing Sales Value, 2019-2030
5.2.2 North America Nucleic Acid Amplification Testing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Nucleic Acid Amplification Testing Sales Value, 2019-2030
5.3.2 Europe Nucleic Acid Amplification Testing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Nucleic Acid Amplification Testing Sales Value, 2019-2030
5.4.2 Asia Pacific Nucleic Acid Amplification Testing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Nucleic Acid Amplification Testing Sales Value, 2019-2030
5.5.2 South America Nucleic Acid Amplification Testing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Nucleic Acid Amplification Testing Sales Value, 2019-2030
5.6.2 Middle East & Africa Nucleic Acid Amplification Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Nucleic Acid Amplification Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Nucleic Acid Amplification Testing Sales Value
6.3 United States
6.3.1 United States Nucleic Acid Amplification Testing Sales Value, 2019-2030
6.3.2 United States Nucleic Acid Amplification Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Nucleic Acid Amplification Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Nucleic Acid Amplification Testing Sales Value, 2019-2030
6.4.2 Europe Nucleic Acid Amplification Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Nucleic Acid Amplification Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Nucleic Acid Amplification Testing Sales Value, 2019-2030
6.5.2 China Nucleic Acid Amplification Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Nucleic Acid Amplification Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Nucleic Acid Amplification Testing Sales Value, 2019-2030
6.6.2 Japan Nucleic Acid Amplification Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Nucleic Acid Amplification Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Nucleic Acid Amplification Testing Sales Value, 2019-2030
6.7.2 South Korea Nucleic Acid Amplification Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Nucleic Acid Amplification Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Nucleic Acid Amplification Testing Sales Value, 2019-2030
6.8.2 Southeast Asia Nucleic Acid Amplification Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Nucleic Acid Amplification Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Nucleic Acid Amplification Testing Sales Value, 2019-2030
6.9.2 India Nucleic Acid Amplification Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Nucleic Acid Amplification Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Roche
7.1.1 Roche Profile
7.1.2 Roche Main Business
7.1.3 Roche Nucleic Acid Amplification Testing Products, Services and Solutions
7.1.4 Roche Nucleic Acid Amplification Testing Revenue (US$ Million) & (2019-2024)
7.1.5 Roche Recent Developments
7.2 Becton Dickinson
7.2.1 Becton Dickinson Profile
7.2.2 Becton Dickinson Main Business
7.2.3 Becton Dickinson Nucleic Acid Amplification Testing Products, Services and Solutions
7.2.4 Becton Dickinson Nucleic Acid Amplification Testing Revenue (US$ Million) & (2019-2024)
7.2.5 Becton Dickinson Recent Developments
7.3 Beckman Coulter
7.3.1 Beckman Coulter Profile
7.3.2 Beckman Coulter Main Business
7.3.3 Beckman Coulter Nucleic Acid Amplification Testing Products, Services and Solutions
7.3.4 Beckman Coulter Nucleic Acid Amplification Testing Revenue (US$ Million) & (2019-2024)
7.3.5 Abbott Recent Developments
7.4 Abbott
7.4.1 Abbott Profile
7.4.2 Abbott Main Business
7.4.3 Abbott Nucleic Acid Amplification Testing Products, Services and Solutions
7.4.4 Abbott Nucleic Acid Amplification Testing Revenue (US$ Million) & (2019-2024)
7.4.5 Abbott Recent Developments
7.5 Illumina
7.5.1 Illumina Profile
7.5.2 Illumina Main Business
7.5.3 Illumina Nucleic Acid Amplification Testing Products, Services and Solutions
7.5.4 Illumina Nucleic Acid Amplification Testing Revenue (US$ Million) & (2019-2024)
7.5.5 Illumina Recent Developments
7.6 Siemens Healthineers
7.6.1 Siemens Healthineers Profile
7.6.2 Siemens Healthineers Main Business
7.6.3 Siemens Healthineers Nucleic Acid Amplification Testing Products, Services and Solutions
7.6.4 Siemens Healthineers Nucleic Acid Amplification Testing Revenue (US$ Million) & (2019-2024)
7.6.5 Siemens Healthineers Recent Developments
7.7 bioMerieux
7.7.1 bioMerieux Profile
7.7.2 bioMerieux Main Business
7.7.3 bioMerieux Nucleic Acid Amplification Testing Products, Services and Solutions
7.7.4 bioMerieux Nucleic Acid Amplification Testing Revenue (US$ Million) & (2019-2024)
7.7.5 bioMerieux Recent Developments
7.8 Novartis
7.8.1 Novartis Profile
7.8.2 Novartis Main Business
7.8.3 Novartis Nucleic Acid Amplification Testing Products, Services and Solutions
7.8.4 Novartis Nucleic Acid Amplification Testing Revenue (US$ Million) & (2019-2024)
7.8.5 Novartis Recent Developments
7.9 Bio-Rad Laboratories
7.9.1 Bio-Rad Laboratories Profile
7.9.2 Bio-Rad Laboratories Main Business
7.9.3 Bio-Rad Laboratories Nucleic Acid Amplification Testing Products, Services and Solutions
7.9.4 Bio-Rad Laboratories Nucleic Acid Amplification Testing Revenue (US$ Million) & (2019-2024)
7.9.5 Bio-Rad Laboratories Recent Developments
8 Industry Chain Analysis
8.1 Nucleic Acid Amplification Testing Industrial Chain
8.2 Nucleic Acid Amplification Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Nucleic Acid Amplification Testing Sales Model
8.5.2 Sales Channel
8.5.3 Nucleic Acid Amplification Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Nucleic Acid Amplification Testing Market Trends
Table 2. Nucleic Acid Amplification Testing Market Drivers & Opportunity
Table 3. Nucleic Acid Amplification Testing Market Challenges
Table 4. Nucleic Acid Amplification Testing Market Restraints
Table 5. Global Nucleic Acid Amplification Testing Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Nucleic Acid Amplification Testing Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Nucleic Acid Amplification Testing Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Nucleic Acid Amplification Testing Product Type
Table 9. Key Companies Time to Begin Mass Production of Nucleic Acid Amplification Testing
Table 10. Global Nucleic Acid Amplification Testing Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Amplification Testing as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Nucleic Acid Amplification Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Nucleic Acid Amplification Testing Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Nucleic Acid Amplification Testing Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Nucleic Acid Amplification Testing Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Nucleic Acid Amplification Testing Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Nucleic Acid Amplification Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Nucleic Acid Amplification Testing Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Nucleic Acid Amplification Testing Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Nucleic Acid Amplification Testing Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Nucleic Acid Amplification Testing Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Nucleic Acid Amplification Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Nucleic Acid Amplification Testing Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Nucleic Acid Amplification Testing Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Nucleic Acid Amplification Testing Sales Value by Region (2019-2024) & (%)
Table 27. Global Nucleic Acid Amplification Testing Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Nucleic Acid Amplification Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Nucleic Acid Amplification Testing Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Nucleic Acid Amplification Testing Sales Value, (2025-2030) & (US$ Million)
Table 31. Roche Basic Information List
Table 32. Roche Description and Business Overview
Table 33. Roche Nucleic Acid Amplification Testing Products, Services and Solutions
Table 34. Revenue (US$ Million) in Nucleic Acid Amplification Testing Business of Roche (2019-2024)
Table 35. Roche Recent Developments
Table 36. Becton Dickinson Basic Information List
Table 37. Becton Dickinson Description and Business Overview
Table 38. Becton Dickinson Nucleic Acid Amplification Testing Products, Services and Solutions
Table 39. Revenue (US$ Million) in Nucleic Acid Amplification Testing Business of Becton Dickinson (2019-2024)
Table 40. Becton Dickinson Recent Developments
Table 41. Beckman Coulter Basic Information List
Table 42. Beckman Coulter Description and Business Overview
Table 43. Beckman Coulter Nucleic Acid Amplification Testing Products, Services and Solutions
Table 44. Revenue (US$ Million) in Nucleic Acid Amplification Testing Business of Beckman Coulter (2019-2024)
Table 45. Beckman Coulter Recent Developments
Table 46. Abbott Basic Information List
Table 47. Abbott Description and Business Overview
Table 48. Abbott Nucleic Acid Amplification Testing Products, Services and Solutions
Table 49. Revenue (US$ Million) in Nucleic Acid Amplification Testing Business of Abbott (2019-2024)
Table 50. Abbott Recent Developments
Table 51. Illumina Basic Information List
Table 52. Illumina Description and Business Overview
Table 53. Illumina Nucleic Acid Amplification Testing Products, Services and Solutions
Table 54. Revenue (US$ Million) in Nucleic Acid Amplification Testing Business of Illumina (2019-2024)
Table 55. Illumina Recent Developments
Table 56. Siemens Healthineers Basic Information List
Table 57. Siemens Healthineers Description and Business Overview
Table 58. Siemens Healthineers Nucleic Acid Amplification Testing Products, Services and Solutions
Table 59. Revenue (US$ Million) in Nucleic Acid Amplification Testing Business of Siemens Healthineers (2019-2024)
Table 60. Siemens Healthineers Recent Developments
Table 61. bioMerieux Basic Information List
Table 62. bioMerieux Description and Business Overview
Table 63. bioMerieux Nucleic Acid Amplification Testing Products, Services and Solutions
Table 64. Revenue (US$ Million) in Nucleic Acid Amplification Testing Business of bioMerieux (2019-2024)
Table 65. bioMerieux Recent Developments
Table 66. Novartis Basic Information List
Table 67. Novartis Description and Business Overview
Table 68. Novartis Nucleic Acid Amplification Testing Products, Services and Solutions
Table 69. Revenue (US$ Million) in Nucleic Acid Amplification Testing Business of Novartis (2019-2024)
Table 70. Novartis Recent Developments
Table 71. Bio-Rad Laboratories Basic Information List
Table 72. Bio-Rad Laboratories Description and Business Overview
Table 73. Bio-Rad Laboratories Nucleic Acid Amplification Testing Products, Services and Solutions
Table 74. Revenue (US$ Million) in Nucleic Acid Amplification Testing Business of Bio-Rad Laboratories (2019-2024)
Table 75. Bio-Rad Laboratories Recent Developments
Table 76. Key Raw Materials Lists
Table 77. Raw Materials Key Suppliers Lists
Table 78. Nucleic Acid Amplification Testing Downstream Customers
Table 79. Nucleic Acid Amplification Testing Distributors List
Table 80. Research Programs/Design for This Report
Table 81. Key Data Information from Secondary Sources
Table 82. Key Data Information from Primary Sources
Table 83. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Nucleic Acid Amplification Testing Product Picture
Figure 2. Global Nucleic Acid Amplification Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Nucleic Acid Amplification Testing Sales Value (2019-2030) & (US$ Million)
Figure 4. Nucleic Acid Amplification Testing Report Years Considered
Figure 5. Global Nucleic Acid Amplification Testing Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Nucleic Acid Amplification Testing Revenue in 2023
Figure 7. Nucleic Acid Amplification Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Target Amplification Systems Picture
Figure 9. Probe Amplification Systems Picture
Figure 10. Signal Amplification Picture
Figure 11. Global Nucleic Acid Amplification Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Nucleic Acid Amplification Testing Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Infectious Diseases
Figure 14. Product Picture of Cancer
Figure 15. Product Picture of Personalized Medicine
Figure 16. Product Picture of Genetic and Mitochondrial Disorders
Figure 17. Global Nucleic Acid Amplification Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Nucleic Acid Amplification Testing Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Nucleic Acid Amplification Testing Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Nucleic Acid Amplification Testing Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Nucleic Acid Amplification Testing Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Nucleic Acid Amplification Testing Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Nucleic Acid Amplification Testing Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Nucleic Acid Amplification Testing Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Nucleic Acid Amplification Testing Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Nucleic Acid Amplification Testing Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Nucleic Acid Amplification Testing Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Nucleic Acid Amplification Testing Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Nucleic Acid Amplification Testing Sales Value (%), (2019-2030)
Figure 30. United States Nucleic Acid Amplification Testing Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Nucleic Acid Amplification Testing Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Nucleic Acid Amplification Testing Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Nucleic Acid Amplification Testing Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Nucleic Acid Amplification Testing Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Nucleic Acid Amplification Testing Sales Value by Application (%), 2023 VS 2030
Figure 36. China Nucleic Acid Amplification Testing Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Nucleic Acid Amplification Testing Sales Value by Type (%), 2023 VS 2030
Figure 38. China Nucleic Acid Amplification Testing Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Nucleic Acid Amplification Testing Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Nucleic Acid Amplification Testing Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Nucleic Acid Amplification Testing Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Nucleic Acid Amplification Testing Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Nucleic Acid Amplification Testing Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Nucleic Acid Amplification Testing Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Nucleic Acid Amplification Testing Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Nucleic Acid Amplification Testing Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Nucleic Acid Amplification Testing Sales Value by Application (%), 2023 VS 2030
Figure 48. India Nucleic Acid Amplification Testing Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Nucleic Acid Amplification Testing Sales Value by Type (%), 2023 VS 2030
Figure 50. India Nucleic Acid Amplification Testing Sales Value by Application (%), 2023 VS 2030
Figure 51. Nucleic Acid Amplification Testing Industrial Chain
Figure 52. Nucleic Acid Amplification Testing Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Table 1. Nucleic Acid Amplification Testing Market Trends
Table 2. Nucleic Acid Amplification Testing Market Drivers & Opportunity
Table 3. Nucleic Acid Amplification Testing Market Challenges
Table 4. Nucleic Acid Amplification Testing Market Restraints
Table 5. Global Nucleic Acid Amplification Testing Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Nucleic Acid Amplification Testing Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Nucleic Acid Amplification Testing Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Nucleic Acid Amplification Testing Product Type
Table 9. Key Companies Time to Begin Mass Production of Nucleic Acid Amplification Testing
Table 10. Global Nucleic Acid Amplification Testing Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Amplification Testing as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Nucleic Acid Amplification Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Nucleic Acid Amplification Testing Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Nucleic Acid Amplification Testing Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Nucleic Acid Amplification Testing Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Nucleic Acid Amplification Testing Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Nucleic Acid Amplification Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Nucleic Acid Amplification Testing Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Nucleic Acid Amplification Testing Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Nucleic Acid Amplification Testing Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Nucleic Acid Amplification Testing Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Nucleic Acid Amplification Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Nucleic Acid Amplification Testing Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Nucleic Acid Amplification Testing Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Nucleic Acid Amplification Testing Sales Value by Region (2019-2024) & (%)
Table 27. Global Nucleic Acid Amplification Testing Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Nucleic Acid Amplification Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Nucleic Acid Amplification Testing Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Nucleic Acid Amplification Testing Sales Value, (2025-2030) & (US$ Million)
Table 31. Roche Basic Information List
Table 32. Roche Description and Business Overview
Table 33. Roche Nucleic Acid Amplification Testing Products, Services and Solutions
Table 34. Revenue (US$ Million) in Nucleic Acid Amplification Testing Business of Roche (2019-2024)
Table 35. Roche Recent Developments
Table 36. Becton Dickinson Basic Information List
Table 37. Becton Dickinson Description and Business Overview
Table 38. Becton Dickinson Nucleic Acid Amplification Testing Products, Services and Solutions
Table 39. Revenue (US$ Million) in Nucleic Acid Amplification Testing Business of Becton Dickinson (2019-2024)
Table 40. Becton Dickinson Recent Developments
Table 41. Beckman Coulter Basic Information List
Table 42. Beckman Coulter Description and Business Overview
Table 43. Beckman Coulter Nucleic Acid Amplification Testing Products, Services and Solutions
Table 44. Revenue (US$ Million) in Nucleic Acid Amplification Testing Business of Beckman Coulter (2019-2024)
Table 45. Beckman Coulter Recent Developments
Table 46. Abbott Basic Information List
Table 47. Abbott Description and Business Overview
Table 48. Abbott Nucleic Acid Amplification Testing Products, Services and Solutions
Table 49. Revenue (US$ Million) in Nucleic Acid Amplification Testing Business of Abbott (2019-2024)
Table 50. Abbott Recent Developments
Table 51. Illumina Basic Information List
Table 52. Illumina Description and Business Overview
Table 53. Illumina Nucleic Acid Amplification Testing Products, Services and Solutions
Table 54. Revenue (US$ Million) in Nucleic Acid Amplification Testing Business of Illumina (2019-2024)
Table 55. Illumina Recent Developments
Table 56. Siemens Healthineers Basic Information List
Table 57. Siemens Healthineers Description and Business Overview
Table 58. Siemens Healthineers Nucleic Acid Amplification Testing Products, Services and Solutions
Table 59. Revenue (US$ Million) in Nucleic Acid Amplification Testing Business of Siemens Healthineers (2019-2024)
Table 60. Siemens Healthineers Recent Developments
Table 61. bioMerieux Basic Information List
Table 62. bioMerieux Description and Business Overview
Table 63. bioMerieux Nucleic Acid Amplification Testing Products, Services and Solutions
Table 64. Revenue (US$ Million) in Nucleic Acid Amplification Testing Business of bioMerieux (2019-2024)
Table 65. bioMerieux Recent Developments
Table 66. Novartis Basic Information List
Table 67. Novartis Description and Business Overview
Table 68. Novartis Nucleic Acid Amplification Testing Products, Services and Solutions
Table 69. Revenue (US$ Million) in Nucleic Acid Amplification Testing Business of Novartis (2019-2024)
Table 70. Novartis Recent Developments
Table 71. Bio-Rad Laboratories Basic Information List
Table 72. Bio-Rad Laboratories Description and Business Overview
Table 73. Bio-Rad Laboratories Nucleic Acid Amplification Testing Products, Services and Solutions
Table 74. Revenue (US$ Million) in Nucleic Acid Amplification Testing Business of Bio-Rad Laboratories (2019-2024)
Table 75. Bio-Rad Laboratories Recent Developments
Table 76. Key Raw Materials Lists
Table 77. Raw Materials Key Suppliers Lists
Table 78. Nucleic Acid Amplification Testing Downstream Customers
Table 79. Nucleic Acid Amplification Testing Distributors List
Table 80. Research Programs/Design for This Report
Table 81. Key Data Information from Secondary Sources
Table 82. Key Data Information from Primary Sources
Table 83. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Nucleic Acid Amplification Testing Product Picture
Figure 2. Global Nucleic Acid Amplification Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Nucleic Acid Amplification Testing Sales Value (2019-2030) & (US$ Million)
Figure 4. Nucleic Acid Amplification Testing Report Years Considered
Figure 5. Global Nucleic Acid Amplification Testing Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Nucleic Acid Amplification Testing Revenue in 2023
Figure 7. Nucleic Acid Amplification Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Target Amplification Systems Picture
Figure 9. Probe Amplification Systems Picture
Figure 10. Signal Amplification Picture
Figure 11. Global Nucleic Acid Amplification Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Nucleic Acid Amplification Testing Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Infectious Diseases
Figure 14. Product Picture of Cancer
Figure 15. Product Picture of Personalized Medicine
Figure 16. Product Picture of Genetic and Mitochondrial Disorders
Figure 17. Global Nucleic Acid Amplification Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Nucleic Acid Amplification Testing Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Nucleic Acid Amplification Testing Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Nucleic Acid Amplification Testing Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Nucleic Acid Amplification Testing Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Nucleic Acid Amplification Testing Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Nucleic Acid Amplification Testing Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Nucleic Acid Amplification Testing Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Nucleic Acid Amplification Testing Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Nucleic Acid Amplification Testing Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Nucleic Acid Amplification Testing Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Nucleic Acid Amplification Testing Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Nucleic Acid Amplification Testing Sales Value (%), (2019-2030)
Figure 30. United States Nucleic Acid Amplification Testing Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Nucleic Acid Amplification Testing Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Nucleic Acid Amplification Testing Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Nucleic Acid Amplification Testing Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Nucleic Acid Amplification Testing Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Nucleic Acid Amplification Testing Sales Value by Application (%), 2023 VS 2030
Figure 36. China Nucleic Acid Amplification Testing Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Nucleic Acid Amplification Testing Sales Value by Type (%), 2023 VS 2030
Figure 38. China Nucleic Acid Amplification Testing Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Nucleic Acid Amplification Testing Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Nucleic Acid Amplification Testing Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Nucleic Acid Amplification Testing Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Nucleic Acid Amplification Testing Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Nucleic Acid Amplification Testing Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Nucleic Acid Amplification Testing Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Nucleic Acid Amplification Testing Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Nucleic Acid Amplification Testing Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Nucleic Acid Amplification Testing Sales Value by Application (%), 2023 VS 2030
Figure 48. India Nucleic Acid Amplification Testing Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Nucleic Acid Amplification Testing Sales Value by Type (%), 2023 VS 2030
Figure 50. India Nucleic Acid Amplification Testing Sales Value by Application (%), 2023 VS 2030
Figure 51. Nucleic Acid Amplification Testing Industrial Chain
Figure 52. Nucleic Acid Amplification Testing Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232